HealthStream (NASDAQ:HSTM) Reaches New 12-Month High – Should You Buy?

HealthStream, Inc. (NASDAQ:HSTM)’s share price hit a new 52-week high on Monday . The company traded as high as $33.09 and last traded at $33.02, with a volume of 32091 shares changing hands. The stock had previously closed at $32.19.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Barclays raised their price target on shares of HealthStream from $32.00 to $34.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 23rd. Craig Hallum raised HealthStream to a “strong-buy” rating in a research report on Thursday, October 17th. Finally, Canaccord Genuity Group upped their price target on HealthStream from $28.00 to $29.00 and gave the company a “hold” rating in a report on Wednesday, October 23rd. Two equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $31.50.

HealthStream Trading Up 1.5 %

The stock has a market cap of $1.00 billion, a P/E ratio of 50.06, a price-to-earnings-growth ratio of 4.33 and a beta of 0.35. The company’s fifty day simple moving average is $29.84 and its 200-day simple moving average is $28.78.

HealthStream (NASDAQ:HSTM) last issued its earnings results on Monday, October 21st. The technology company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.06. HealthStream had a net margin of 6.84% and a return on equity of 5.67%. The business had revenue of $73.10 million for the quarter, compared to analyst estimates of $73.53 million. During the same period in the previous year, the business earned $0.13 EPS. The firm’s revenue was up 4.0% on a year-over-year basis. As a group, analysts expect that HealthStream, Inc. will post 0.63 earnings per share for the current fiscal year.

HealthStream Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were issued a $0.028 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $0.11 dividend on an annualized basis and a dividend yield of 0.34%. HealthStream’s payout ratio is presently 16.92%.

Insider Activity at HealthStream

In other HealthStream news, Director Tate Deborah Taylor sold 1,400 shares of the stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $28.53, for a total transaction of $39,942.00. Following the completion of the transaction, the director now directly owns 22,326 shares in the company, valued at $636,960.78. This represents a 5.90 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 20.60% of the stock is owned by insiders.

Institutional Investors Weigh In On HealthStream

Large investors have recently made changes to their positions in the company. Quarry LP bought a new position in HealthStream during the 3rd quarter valued at about $27,000. GAMMA Investing LLC raised its stake in shares of HealthStream by 172.1% in the second quarter. GAMMA Investing LLC now owns 996 shares of the technology company’s stock valued at $28,000 after acquiring an additional 630 shares during the last quarter. Point72 DIFC Ltd acquired a new position in shares of HealthStream in the 2nd quarter worth approximately $38,000. Copeland Capital Management LLC bought a new stake in HealthStream during the 3rd quarter worth approximately $63,000. Finally, CWM LLC increased its holdings in HealthStream by 405.4% during the 2nd quarter. CWM LLC now owns 2,709 shares of the technology company’s stock valued at $76,000 after purchasing an additional 2,173 shares in the last quarter. Institutional investors own 69.58% of the company’s stock.

About HealthStream

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.